Next Article 
Mol Cell Biol. 1993 December; 13(12): 7203-7212
Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.
S M Shamah,
C D Stiles and
A Guha
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115.
ABSTRACT
Malignant astrocytoma is the most common primary human brain tumor. Most astrocytomas express a combination of platelet-derived growth factor (PDGF) and PDGF receptor which could close an autocrine loop. It is not known whether these autocrine loops contribute to the transformed phenotype of astrocytoma cells or are incidental to that phenotype. Here we show that dominant-negative mutants of the PDGF ligand break the autocrine loop and revert the phenotype of BALB/c 3T3 cells transformed by the PDGF-A or PDGF-B (c-sis) gene. Then, we show that these mutants are selective in that they do not alter the phenotype of 3T3 cells transformed by an activated Ha-ras or v-src gene or by simian virus 40. Finally, we show that these mutants revert the transformed phenotype of two independent human astrocytoma cell lines. They have no effect on the growth of human medulloblastoma, bladder carcinoma, or colon carcinoma cell lines. These observations are consistent with the view that PDGF autocrine loops contribute to the transformed phenotype of at least some human astrocytomas.
Mol Cell Biol. 1993 December; 13(12): 7203-7212
This article has been cited by other articles:
-
Werth, C., Stuhlmann, D., Cat, B., Steinbrenner, H., Alili, L., Sies, H., Brenneisen, P.
(2008). Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation. Carcinogenesis
29: 404-410
[Abstract]
[Full Text]
-
Wen, P. Y., Yung, W.K. A., Lamborn, K. R., Dahia, P. L., Wang, Y., Peng, B., Abrey, L. E., Raizer, J., Cloughesy, T. F., Fink, K., Gilbert, M., Chang, S., Junck, L., Schiff, D., Lieberman, F., Fine, H. A., Mehta, M., Robins, H. I., DeAngelis, L. M., Groves, M. D., Puduvalli, V. K., Levin, V., Conrad, C., Maher, E. A., Aldape, K., Hayes, M., Letvak, L., Egorin, M. J., Capdeville, R., Kaplan, R., Murgo, A. J., Stiles, C., Prados, M. D.
(2006). Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08.. Clin. Cancer Res.
12: 4899-4907
[Abstract]
[Full Text]
-
Rand, V., Huang, J., Stockwell, T., Ferriera, S., Buzko, O., Levy, S., Busam, D., Li, K., Edwards, J. B., Eberhart, C., Murphy, K. M., Tsiamouri, A., Beeson, K., Simpson, A. J. G., Venter, J. C., Riggins, G. J., Strausberg, R. L.
(2005). Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc. Natl. Acad. Sci. USA
102: 14344-14349
[Abstract]
[Full Text]
-
Ma, D., Nutt, C. L., Shanehsaz, P., Peng, X., Louis, D. N., Kaetzel, D. M.
(2005). Autocrine Platelet-Derived Growth Factor-Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Altered Genotype and Patient Survival in Human Brain Tumors. Cancer Res.
65: 5523-5534
[Abstract]
[Full Text]
-
Furuhashi, M., Sjoblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H., Bergsten-Folestad, E., Eriksson, U., Heuchel, R., Betsholtz, C., Heldin, C.-H., Ostman, A.
(2004). Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate. Cancer Res.
64: 2725-2733
[Abstract]
[Full Text]
-
Hwang, R. F., Yokoi, K., Bucana, C. D., Tsan, R., Killion, J. J., Evans, D. B., Fidler, I. J.
(2003). Inhibition of Platelet-Derived Growth Factor Receptor Phosphorylation by STI571 (Gleevec) Reduces Growth and Metastasis of Human Pancreatic Carcinoma in an Orthotopic Nude Mouse Model. Clin. Cancer Res.
9: 6534-6544
[Abstract]
[Full Text]
-
Huang, Z.-y., Wu, Y., Burke, S. P., Gutmann, D. H.
(2003). The 43,000 Growth-associated Protein Functions as a Negative Growth Regulator in Glioma. Cancer Res.
63: 2933-2939
[Abstract]
[Full Text]
-
Arbiser, J. L., Govindarajan, B., Bai, X., Onda, H., Kazlauskas, A., Lim, S. D., Amin, M. B., Claesson-Welsh, L.
(2002). Functional Tyrosine Kinase Inhibitor Profiling : A Generally Applicable Method Points to a Novel Role of Platelet-Derived Growth Factor Receptor-{beta} in Tuberous Sclerosis. Am. J. Pathol.
161: 781-786
[Abstract]
[Full Text]
-
Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., Giese, N. A.
(2002). Platelet-derived Growth Factor (PDGF) Autocrine Signaling Regulates Survival and Mitogenic Pathways in Glioblastoma Cells: Evidence That the Novel PDGF-C and PDGF-D Ligands May Play a Role in the Development of Brain Tumors. Cancer Res.
62: 3729-3735
[Abstract]
[Full Text]
-
Sjoblom, T., Shimizu, A., O'Brien, K. P., Pietras, K., Dal Cin, P., Buchdunger, E., Dumanski, J. P., Ostman, A., Heldin, C.-H.
(2001). Growth Inhibition of Dermatofibrosarcoma Protuberans Tumors by the Platelet-derived Growth Factor Receptor Antagonist STI571 through Induction of Apoptosis. Cancer Res.
61: 5778-5783
[Abstract]
[Full Text]
-
Wilcox, M. E., Yang, W., Senger, D., Rewcastle, N. B., Morris, D. G., Brasher, P. M. A., Shi, Z. Q., Johnston, R. N., Nishikawa, S., Lee, P. W. K., Forsyth, P. A.
(2001). Reovirus as an Oncolytic Agent Against Experimental Human Malignant Gliomas. JNCI J Natl Cancer Inst
93: 903-912
[Abstract]
[Full Text]
-
Metheny-Barlow, L. J., Flynn, B., van Gijssel, H. E., Marrogi, A., Gerwin, B. I.
(2001). Paradoxical Effects of Platelet-Derived Growth Factor-A Overexpression in Malignant Mesothelioma . Antiproliferative Effects In Vitro and Tumorigenic Stimulation In Vivo. Am. J. Respir. Cell Mol. Bio.
24: 694-702
[Abstract]
[Full Text]
-
Ding, H., Roncari, L., Shannon, P., Wu, X., Lau, N., Karaskova, J., Gutmann, D. H., Squire, J. A., Nagy, A., Guha, A.
(2001). Astrocyte-specific Expression of Activated p21-ras Results in Malignant Astrocytoma Formation in a Transgenic Mouse Model of Human Gliomas. Cancer Res.
61: 3826-3836
[Abstract]
[Full Text]
-
Kilic, T., Alberta, J. A., Zdunek, P. R., Acar, M., Iannarelli, P., OReilly, T., Buchdunger, E., Black, P. M., Stiles, C. D.
(2000). Intracranial Inhibition of Platelet-derived Growth Factor-mediated Glioblastoma Cell Growth by an Orally Active Kinase Inhibitor of the 2-Phenylaminopyrimidine Class. Cancer Res.
60: 5143-5150
[Abstract]
[Full Text]
-
Heldin, C.-H., Westermark, B.
(1999). Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor. Physiol. Rev.
79: 1283-1316
[Abstract]
[Full Text]
-
Coffey, M. C., Strong, J. E., Forsyth, P. A., Lee, P. W.
(1998). Reovirus Therapy of Tumors with Activated Ras Pathway. Science
282: 1332-1334
[Abstract]
[Full Text]
-
Mandell, J. W., Hussaini, I. M., Zecevic, M., Weber, M. J., VandenBerg, S. R.
(1998). In Situ Visualization of Intratumor Growth Factor Signaling : Immunohistochemical Localization of Activated ERK/MAP Kinase in Glial Neoplasms. Am. J. Pathol.
153: 1411-1423
[Abstract]
[Full Text]
-
Siemeister, G., Schirner, M., Reusch, P., Barleon, B., Marme, D., Martiny-Baron, G.
(1998). An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA
95: 4625-4629
[Abstract]
[Full Text]
-
Zhang, N., Zhong, R., Wang, Z.-Y., Deuel, T. F.
(1997). Human Breast Cancer Growth Inhibited in Vivo by a Dominant Negative Pleiotrophin Mutant. J. Biol. Chem.
272: 16733-16736
[Abstract]
[Full Text]
-
Omura, T., Heldin, C.-H., Ostman, A.
(1997). Immunoglobulin-like Domain 4-mediated Receptor-Receptor Interactions Contribute to Platelet-derived Growth Factor-induced Receptor Dimerization. J. Biol. Chem.
272: 12676-12682
[Abstract]
[Full Text]
-
DeMali, K. A., Whiteford, C. C., Ulug, E. T., Kazlauskas, A.
(1997). Platelet-derived Growth Factor-dependent Cellular Transformation Requires Either Phospholipase Cgamma or Phosphatidylinositol 3Kinase. J. Biol. Chem.
272: 9011-9018
[Abstract]
[Full Text]
-
Liu, B., Maul, R. S., Kaetzel, D. M. Jr.
(1996). Repression of Platelet-derived Growth Factor A-chain Gene Transcription by an Upstream Silencer Element. PARTICIPATION BY SEQUENCE-SPECIFIC SINGLE-STRANDED DNA-BINDING PROTEINS. J. Biol. Chem.
271: 26281-26290
[Abstract]
[Full Text]
-
Liang, Y., Robinson, D. F., Dennig, Jör., Suske, G., Fahl, W. E.
(1996). Transcriptional Regulation of the SIS/PDGF-B Gene in Human Osteosarcoma Cells by the Sp Family of Transcription Factors. J. Biol. Chem.
271: 11792-11797
[Abstract]
[Full Text]
-
Valgeirsdóttir, S., Eriksson, A., Nistér, M., Heldin, C.-H., Westermark, B., Claesson-Welsh, L.
(1995). Compartmentalization of Autocrine Signal Transduction Pathways in Sis-transformed NIH 3T3 Cells. J. Biol. Chem.
270: 10161-10170
[Abstract]
[Full Text]
-
Chen, Q.-P., Giannobile, W. V.
(2002). Adenoviral gene transfer of PDGF downregulates gas gene product PDGFalpha R and prolongs ERK and Akt/PKB activation. Am. J. Physiol. Cell Physiol.
282: C538-C544
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.